Serum Albumin Nanoparticles: Problems and Prospects

The present paper aims to summarize the results regarding serum albumin-based nanoparticles (NPs) for drug delivery purposes. In particular, it focuses on the relationship between their preparation techniques and synthesis parameters, as well as their successful clinical application. In spite of the...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Polymers 2021-10, Vol.13 (21), p.3759
1. Verfasser: Hornok, Viktória
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue 21
container_start_page 3759
container_title Polymers
container_volume 13
creator Hornok, Viktória
description The present paper aims to summarize the results regarding serum albumin-based nanoparticles (NPs) for drug delivery purposes. In particular, it focuses on the relationship between their preparation techniques and synthesis parameters, as well as their successful clinical application. In spite of the huge amount of consumed material and immaterial sources and promising possibilities, products made from different types of albumin NPs, with the exception of a few, still have not been invented. In the present paper, promising applications of serum albumin nanoparticles (SANPs) for different biomedical purposes, such as carriers, delivery systems and contrast agents, are also discussed. The most frequent utilization of the NPs for certain diseases, i.e., cancer therapy, and future prospects are also detailed in this study.
doi_str_mv 10.3390/polym13213759
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8586933</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2597496061</sourcerecordid><originalsourceid>FETCH-LOGICAL-c481t-270400e66399a7d5339b8d71050d7e72c32f84028fa8441e14d119e32d5b885c3</originalsourceid><addsrcrecordid>eNpdkctLw0AQxhdRbKk9epWCFy_R3cw-PQil-AJRQT0vm2SjKZuHu4nQ_96E1tI6l5lhfnx8M4PQKcGXAApfNbVblQRiAoKpAzSOsYCIAseHO_UITUNY4j4o45yIYzQCKgQBwscI3qzvytncJV1ZVLNnU9WN8W2ROhuuZ6--Tpwtw8xU2dCExqZtOEFHuXHBTjd5gj7ubt8XD9HTy_3jYv4UpVSSNooFphhbzkEpIzLWO05kJghmOBNWxCnEuaQ4lrmRlBJLaEaIshBnLJGSpTBBN2vdpktKm6W2ar1xuvFFafxK16bQ-5Oq-NKf9Y-WTHIF0AtcbAR8_d3Z0OqyCKl1zlS27oKOmRJUccxJj57_Q5d156t-vYHivWciBsFoTaX9LYK3-dYMwXr4iN77SM-f7W6wpf_uD79XUoWK</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2596050173</pqid></control><display><type>article</type><title>Serum Albumin Nanoparticles: Problems and Prospects</title><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central Open Access</source><source>MDPI - Multidisciplinary Digital Publishing Institute</source><source>PubMed Central</source><creator>Hornok, Viktória</creator><creatorcontrib>Hornok, Viktória</creatorcontrib><description>The present paper aims to summarize the results regarding serum albumin-based nanoparticles (NPs) for drug delivery purposes. In particular, it focuses on the relationship between their preparation techniques and synthesis parameters, as well as their successful clinical application. In spite of the huge amount of consumed material and immaterial sources and promising possibilities, products made from different types of albumin NPs, with the exception of a few, still have not been invented. In the present paper, promising applications of serum albumin nanoparticles (SANPs) for different biomedical purposes, such as carriers, delivery systems and contrast agents, are also discussed. The most frequent utilization of the NPs for certain diseases, i.e., cancer therapy, and future prospects are also detailed in this study.</description><identifier>ISSN: 2073-4360</identifier><identifier>EISSN: 2073-4360</identifier><identifier>DOI: 10.3390/polym13213759</identifier><identifier>PMID: 34771316</identifier><language>eng</language><publisher>Switzerland: MDPI AG</publisher><subject>Amino acids ; Binding sites ; Biomedical materials ; Cancer therapies ; Clinical trials ; Contrast agents ; Drug delivery systems ; Drugs ; Nanoparticles ; Peptides ; Plasma ; Proteins ; Review ; Serum albumin ; Tumors</subject><ispartof>Polymers, 2021-10, Vol.13 (21), p.3759</ispartof><rights>2021 by the author. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2021 by the author. 2021</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c481t-270400e66399a7d5339b8d71050d7e72c32f84028fa8441e14d119e32d5b885c3</citedby><cites>FETCH-LOGICAL-c481t-270400e66399a7d5339b8d71050d7e72c32f84028fa8441e14d119e32d5b885c3</cites><orcidid>0000-0001-9933-7604</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8586933/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8586933/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,725,778,782,883,27907,27908,53774,53776</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34771316$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Hornok, Viktória</creatorcontrib><title>Serum Albumin Nanoparticles: Problems and Prospects</title><title>Polymers</title><addtitle>Polymers (Basel)</addtitle><description>The present paper aims to summarize the results regarding serum albumin-based nanoparticles (NPs) for drug delivery purposes. In particular, it focuses on the relationship between their preparation techniques and synthesis parameters, as well as their successful clinical application. In spite of the huge amount of consumed material and immaterial sources and promising possibilities, products made from different types of albumin NPs, with the exception of a few, still have not been invented. In the present paper, promising applications of serum albumin nanoparticles (SANPs) for different biomedical purposes, such as carriers, delivery systems and contrast agents, are also discussed. The most frequent utilization of the NPs for certain diseases, i.e., cancer therapy, and future prospects are also detailed in this study.</description><subject>Amino acids</subject><subject>Binding sites</subject><subject>Biomedical materials</subject><subject>Cancer therapies</subject><subject>Clinical trials</subject><subject>Contrast agents</subject><subject>Drug delivery systems</subject><subject>Drugs</subject><subject>Nanoparticles</subject><subject>Peptides</subject><subject>Plasma</subject><subject>Proteins</subject><subject>Review</subject><subject>Serum albumin</subject><subject>Tumors</subject><issn>2073-4360</issn><issn>2073-4360</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><recordid>eNpdkctLw0AQxhdRbKk9epWCFy_R3cw-PQil-AJRQT0vm2SjKZuHu4nQ_96E1tI6l5lhfnx8M4PQKcGXAApfNbVblQRiAoKpAzSOsYCIAseHO_UITUNY4j4o45yIYzQCKgQBwscI3qzvytncJV1ZVLNnU9WN8W2ROhuuZ6--Tpwtw8xU2dCExqZtOEFHuXHBTjd5gj7ubt8XD9HTy_3jYv4UpVSSNooFphhbzkEpIzLWO05kJghmOBNWxCnEuaQ4lrmRlBJLaEaIshBnLJGSpTBBN2vdpktKm6W2ar1xuvFFafxK16bQ-5Oq-NKf9Y-WTHIF0AtcbAR8_d3Z0OqyCKl1zlS27oKOmRJUccxJj57_Q5d156t-vYHivWciBsFoTaX9LYK3-dYMwXr4iN77SM-f7W6wpf_uD79XUoWK</recordid><startdate>20211030</startdate><enddate>20211030</enddate><creator>Hornok, Viktória</creator><general>MDPI AG</general><general>MDPI</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7SR</scope><scope>8FD</scope><scope>8FE</scope><scope>8FG</scope><scope>ABJCF</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>BGLVJ</scope><scope>CCPQU</scope><scope>D1I</scope><scope>DWQXO</scope><scope>HCIFZ</scope><scope>JG9</scope><scope>KB.</scope><scope>PDBOC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0001-9933-7604</orcidid></search><sort><creationdate>20211030</creationdate><title>Serum Albumin Nanoparticles: Problems and Prospects</title><author>Hornok, Viktória</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c481t-270400e66399a7d5339b8d71050d7e72c32f84028fa8441e14d119e32d5b885c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Amino acids</topic><topic>Binding sites</topic><topic>Biomedical materials</topic><topic>Cancer therapies</topic><topic>Clinical trials</topic><topic>Contrast agents</topic><topic>Drug delivery systems</topic><topic>Drugs</topic><topic>Nanoparticles</topic><topic>Peptides</topic><topic>Plasma</topic><topic>Proteins</topic><topic>Review</topic><topic>Serum albumin</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hornok, Viktória</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>Engineered Materials Abstracts</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Technology Collection</collection><collection>Materials Science &amp; Engineering Collection</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>Technology Collection (ProQuest)</collection><collection>ProQuest One Community College</collection><collection>ProQuest Materials Science Collection</collection><collection>ProQuest Central Korea</collection><collection>SciTech Premium Collection</collection><collection>Materials Research Database</collection><collection>Materials Science Database</collection><collection>Materials Science Collection</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Polymers</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hornok, Viktória</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Serum Albumin Nanoparticles: Problems and Prospects</atitle><jtitle>Polymers</jtitle><addtitle>Polymers (Basel)</addtitle><date>2021-10-30</date><risdate>2021</risdate><volume>13</volume><issue>21</issue><spage>3759</spage><pages>3759-</pages><issn>2073-4360</issn><eissn>2073-4360</eissn><abstract>The present paper aims to summarize the results regarding serum albumin-based nanoparticles (NPs) for drug delivery purposes. In particular, it focuses on the relationship between their preparation techniques and synthesis parameters, as well as their successful clinical application. In spite of the huge amount of consumed material and immaterial sources and promising possibilities, products made from different types of albumin NPs, with the exception of a few, still have not been invented. In the present paper, promising applications of serum albumin nanoparticles (SANPs) for different biomedical purposes, such as carriers, delivery systems and contrast agents, are also discussed. The most frequent utilization of the NPs for certain diseases, i.e., cancer therapy, and future prospects are also detailed in this study.</abstract><cop>Switzerland</cop><pub>MDPI AG</pub><pmid>34771316</pmid><doi>10.3390/polym13213759</doi><orcidid>https://orcid.org/0000-0001-9933-7604</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2073-4360
ispartof Polymers, 2021-10, Vol.13 (21), p.3759
issn 2073-4360
2073-4360
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8586933
source Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central Open Access; MDPI - Multidisciplinary Digital Publishing Institute; PubMed Central
subjects Amino acids
Binding sites
Biomedical materials
Cancer therapies
Clinical trials
Contrast agents
Drug delivery systems
Drugs
Nanoparticles
Peptides
Plasma
Proteins
Review
Serum albumin
Tumors
title Serum Albumin Nanoparticles: Problems and Prospects
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-16T17%3A11%3A58IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Serum%20Albumin%20Nanoparticles:%20Problems%20and%20Prospects&rft.jtitle=Polymers&rft.au=Hornok,%20Vikt%C3%B3ria&rft.date=2021-10-30&rft.volume=13&rft.issue=21&rft.spage=3759&rft.pages=3759-&rft.issn=2073-4360&rft.eissn=2073-4360&rft_id=info:doi/10.3390/polym13213759&rft_dat=%3Cproquest_pubme%3E2597496061%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2596050173&rft_id=info:pmid/34771316&rfr_iscdi=true